Watchlist Price Alert

Atai Life Sciences N.V. (ATAI)

NASDAQ: ATAI · Real-Time Price · USD

2.23

0.12 (5.69%)

At close: Jun 16, 2025, 3:59 PM

2.24

0.45%

After-hours: Jun 16, 2025, 07:45 PM EDT

5.69% (1D)

Bid	2.15
Market Cap	447.68M
Revenue (ttm)	1.86M
Net Income (ttm)	-148.99M
EPS (ttm)	-0.9
PE Ratio (ttm)	-2.48
Forward PE	-3.71
Analyst	Buy

Ask	2.27
Volume	2,036,600
Avg. Volume (20D)	2,048,887
Open	2.17
Previous Close	2.11
Day's Range	2.12 - 2.25
52-Week Range	1.03 - 2.64
Beta	1.48

About ATAI

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ATAI

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ATAI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 weeks ago

+7.79%

atai Life Sciences shares are trading higher after... Unlock content with Pro Subscription

4 weeks ago

+11.41%

ATAI Life Sciences shares are trading higher after the company announced topline data from part 2 of its Phase 2a study of BPL-003.

News

1 week ago · zacks.com

Are You Looking for a Top Momentum Pick? Why atai Life Sciences N.V.

Does atai Life Sciences N.V. (ATAI) have what it takes to be a top stock pick for momentum investors?

1 week ago · zacks.com

Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year?

Here is how atai Life Sciences N.V. (ATAI) and Novartis (NVS) have performed compared to their sector so far this year.

2 weeks ago · businesswire.com

ATAI Stock Alert: Halper Sadeh LLC is Investigating Whether the Merger of Atai Life Sciences N.V. is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Atai Life Sciences N.V. (NASDAQ: ATAI) and Beckley Psytech Limited is fair to Atai shar...

2 weeks ago · proactiveinvestors.com

atai Life Sciences gains maximum exposure to key psychedelic asset with Beckley Psytech merger

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) stock is poised to move higher following its planned merger with Beckley Psytech, as the combined entity will provide investors with maximum exposure to a pro...

2 weeks ago · https://www.proactiveinvestors.com

Meta to roll out AI-powered ad creation by late 2025, says WSJ

Meta Platforms Inc (NASDAQ:META, ETR:FB2A, SWX:FB) is planning to let brands fully create and target ads using its artificial intelligence tools by the end of 2025, according to a report in the Wall S...

2 weeks ago · proactiveinvestors.com

atai Life Sciences and Beckley Psytech to merge in all-share deal, stock pops

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) shares soared before Monday's opening bell after it announced it has inked a definitive agreement to merge with Beckley Psytech, a private clinical-stage biop...

2 weeks ago · proactiveinvestors.com

atai Life Sciences expects key trial data by mid-2025 - ICYMI

atai Life Sciences (NASDAQ:ATAI, ETR:9VC) CEO and co-founder Dr Srinivas Rao talked with Proactive about the company's clinical development progress in 2025, highlighting multiple upcoming trial reado...